Canine Cancer
AKC Canine Health Foundation Canine Cancer Research
Since 1995, CHF and its donors have funded over $15.4 million in canine cancer research. These 240 research grants have helped scientists study cancer at the cellular level, providing breakthroughs that allow veterinarians to diagnose cancer earlier and treat it more effectively. CHF-funded research also has a One Health impact, extending beyond dogs with an application to human cancer diagnosis and treatment.
Canine cancer research is a major concern of dog owners and veterinary professionals. Typically, about one quarter of CHF’s grant funding concerns various types of canine cancers.
View our Cancer Research Portfolio
Resources
Canine Cancer Articles
A Gene Therapy Clinical Trial for Dogs with Glioma September 12, 2011
Researchers at the University of Minnesota are currently conducting clinical trials to find new and better ways to treat gliomas. In the past 12 months, they have recruited 10 dogs for a gene therapy study. Preliminary data hint at improved times of progression-free as well as overall survival in dogs treated with gene therapy.
Immunotherapy for Canine Meningioma September 12, 2011
Historically, the survival time of dogs with meningiomas treated with surgery alone has been four and one-half to seven months. Systemic therapies so far have had limited effectiveness. However, based on preclinical data from our research program,we embarked on the development of anti-tumor vaccinations to treat dogs with spontaneous meningiomas after surgical removal.
Pilot study assesses feasibility of tissue collections and molecular profiling for personalized medicine studies August 24, 2011
Personalized medicine involves tailoring cancer treatment and prevention to the specific molecular nature of the individual and their cancer. The hope is that targeted therapies will be more effective with less risk for the patient than traditional treatments.
Using Technology to Target Tumors February 25, 2011
Dr. Nicola Mason and her colleagues at the University of Pennsylvania, with the support of the AKC Canine Health Foundation, have been trying to find new ways to use antibody fragments to target a particularly devastating type of canine tumor. They are looking for a more effective treatment for canine hemangiosarcoma.
Malignant Histiocytosis: Looking for a Cure December 1, 2010
The median survival time for malignant histiocytosis is only 2-4 months. Traditional cancer treatments such as radiation and surgery are generally ineffective in dogs with MH. There is hope for the future; however, as preliminary studies of a new form of treatment have shown some real promise.
Resources Available for Download
Webinars
A Novel Non-Surgical Option to Preserve Limbs in Canine Osteosarcoma
Original air date: May 25, 2021
Speaker: Joanne Tuohy, DVM, PhD, DACVS
Recent Advances in Cancer Immunotherapy
Original air date: May 2020
Speaker: Steven Dow, DVM, PhD, Diplomate ACVIM (Oncology)
Update on Canine Hemangiosarcoma
Original air date: May 2017
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Cancer Immunotherapy: Basic Concepts and Strategies for Improving Treatment Outcomes
Original air date: October 2016
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Lymphoma: The State of This Disease in Dogs and How Epigenetics May Open Future Doors
Original air date: June 2016
Speaker: Jeffrey M. Bryan, DVM, MS, PhD, DACVIM (Oncology)
How You Can Help
Your support means more studies exploring improved diagnostics and new treatment strategies for canine cancer.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
